Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC17A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CNTFR-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NOL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NDUFA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1841 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507073 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSTR5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FIBCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTNB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP2A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCARB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XYLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM52-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC4A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on